0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Inhalational Anesthesia Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-27Y13210
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Inhalational Anesthesia Drugs Market Research Report 2023
BUY CHAPTERS

Global Inhalational Anesthesia Drugs Market Research Report 2025

Code: QYRE-Auto-27Y13210
Report
September 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Inhalational Anesthesia Drugs Market Size

The global market for Inhalational Anesthesia Drugs was valued at US$ 1318 million in the year 2024 and is projected to reach a revised size of US$ 1604 million by 2031, growing at a CAGR of 2.9% during the forecast period.

Inhalational Anesthesia Drugs Market

Inhalational Anesthesia Drugs Market

An inhalational anaesthetic is a chemical compound possessing general anaesthetic properties that can be delivered via inhalation.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Inhalational Anesthesia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalational Anesthesia Drugs.
The Inhalational Anesthesia Drugs market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inhalational Anesthesia Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhalational Anesthesia Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Inhalational Anesthesia Drugs Market Report

Report Metric Details
Report Name Inhalational Anesthesia Drugs Market
Accounted market size in year US$ 1318 million
Forecasted market size in 2031 US$ 1604 million
CAGR 2.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Sevoflurane
  • Desflurane
  • Isoflurane
  • Enflurane
Segment by Application
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Baxter, AbbVie, Piramal Enterprises, Halocarbon Products, Jiangsu Hengrui Medicine, Fresenius Kabi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Inhalational Anesthesia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Inhalational Anesthesia Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Inhalational Anesthesia Drugs Market growing?

Ans: The Inhalational Anesthesia Drugs Market witnessing a CAGR of 2.9% during the forecast period 2025-2031.

What is the Inhalational Anesthesia Drugs Market size in 2031?

Ans: The Inhalational Anesthesia Drugs Market size in 2031 will be US$ 1604 million.

Who are the main players in the Inhalational Anesthesia Drugs Market report?

Ans: The main players in the Inhalational Anesthesia Drugs Market are Baxter, AbbVie, Piramal Enterprises, Halocarbon Products, Jiangsu Hengrui Medicine, Fresenius Kabi

What are the Application segmentation covered in the Inhalational Anesthesia Drugs Market report?

Ans: The Applications covered in the Inhalational Anesthesia Drugs Market report are Hospitals, Clinics, Ambulatory Surgical Centers

What are the Type segmentation covered in the Inhalational Anesthesia Drugs Market report?

Ans: The Types covered in the Inhalational Anesthesia Drugs Market report are Sevoflurane, Desflurane, Isoflurane, Enflurane

1 Inhalational Anesthesia Drugs Market Overview
1.1 Product Definition
1.2 Inhalational Anesthesia Drugs by Type
1.2.1 Global Inhalational Anesthesia Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Sevoflurane
1.2.3 Desflurane
1.2.4 Isoflurane
1.2.5 Enflurane
1.3 Inhalational Anesthesia Drugs by Application
1.3.1 Global Inhalational Anesthesia Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Global Inhalational Anesthesia Drugs Market Size Estimates and Forecasts
1.4.1 Global Inhalational Anesthesia Drugs Revenue 2020-2031
1.4.2 Global Inhalational Anesthesia Drugs Sales 2020-2031
1.4.3 Global Inhalational Anesthesia Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Inhalational Anesthesia Drugs Market Competition by Manufacturers
2.1 Global Inhalational Anesthesia Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Inhalational Anesthesia Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Inhalational Anesthesia Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Inhalational Anesthesia Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inhalational Anesthesia Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inhalational Anesthesia Drugs, Product Type & Application
2.7 Global Key Manufacturers of Inhalational Anesthesia Drugs, Date of Enter into This Industry
2.8 Global Inhalational Anesthesia Drugs Market Competitive Situation and Trends
2.8.1 Global Inhalational Anesthesia Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Inhalational Anesthesia Drugs Players Market Share by Revenue
2.8.3 Global Inhalational Anesthesia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inhalational Anesthesia Drugs Market Scenario by Region
3.1 Global Inhalational Anesthesia Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Inhalational Anesthesia Drugs Sales by Region: 2020-2031
3.2.1 Global Inhalational Anesthesia Drugs Sales by Region: 2020-2025
3.2.2 Global Inhalational Anesthesia Drugs Sales by Region: 2026-2031
3.3 Global Inhalational Anesthesia Drugs Revenue by Region: 2020-2031
3.3.1 Global Inhalational Anesthesia Drugs Revenue by Region: 2020-2025
3.3.2 Global Inhalational Anesthesia Drugs Revenue by Region: 2026-2031
3.4 North America Inhalational Anesthesia Drugs Market Facts & Figures by Country
3.4.1 North America Inhalational Anesthesia Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Inhalational Anesthesia Drugs Sales by Country (2020-2031)
3.4.3 North America Inhalational Anesthesia Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Inhalational Anesthesia Drugs Market Facts & Figures by Country
3.5.1 Europe Inhalational Anesthesia Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Inhalational Anesthesia Drugs Sales by Country (2020-2031)
3.5.3 Europe Inhalational Anesthesia Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhalational Anesthesia Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Inhalational Anesthesia Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Inhalational Anesthesia Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Inhalational Anesthesia Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Inhalational Anesthesia Drugs Market Facts & Figures by Country
3.7.1 Latin America Inhalational Anesthesia Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Inhalational Anesthesia Drugs Sales by Country (2020-2031)
3.7.3 Latin America Inhalational Anesthesia Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inhalational Anesthesia Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhalational Anesthesia Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Inhalational Anesthesia Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Inhalational Anesthesia Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Inhalational Anesthesia Drugs Sales by Type (2020-2031)
4.1.1 Global Inhalational Anesthesia Drugs Sales by Type (2020-2025)
4.1.2 Global Inhalational Anesthesia Drugs Sales by Type (2026-2031)
4.1.3 Global Inhalational Anesthesia Drugs Sales Market Share by Type (2020-2031)
4.2 Global Inhalational Anesthesia Drugs Revenue by Type (2020-2031)
4.2.1 Global Inhalational Anesthesia Drugs Revenue by Type (2020-2025)
4.2.2 Global Inhalational Anesthesia Drugs Revenue by Type (2026-2031)
4.2.3 Global Inhalational Anesthesia Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Inhalational Anesthesia Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Inhalational Anesthesia Drugs Sales by Application (2020-2031)
5.1.1 Global Inhalational Anesthesia Drugs Sales by Application (2020-2025)
5.1.2 Global Inhalational Anesthesia Drugs Sales by Application (2026-2031)
5.1.3 Global Inhalational Anesthesia Drugs Sales Market Share by Application (2020-2031)
5.2 Global Inhalational Anesthesia Drugs Revenue by Application (2020-2031)
5.2.1 Global Inhalational Anesthesia Drugs Revenue by Application (2020-2025)
5.2.2 Global Inhalational Anesthesia Drugs Revenue by Application (2026-2031)
5.2.3 Global Inhalational Anesthesia Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Inhalational Anesthesia Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Inhalational Anesthesia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Baxter Inhalational Anesthesia Drugs Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Company Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Inhalational Anesthesia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AbbVie Inhalational Anesthesia Drugs Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 Piramal Enterprises
6.3.1 Piramal Enterprises Company Information
6.3.2 Piramal Enterprises Description and Business Overview
6.3.3 Piramal Enterprises Inhalational Anesthesia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Piramal Enterprises Inhalational Anesthesia Drugs Product Portfolio
6.3.5 Piramal Enterprises Recent Developments/Updates
6.4 Halocarbon Products
6.4.1 Halocarbon Products Company Information
6.4.2 Halocarbon Products Description and Business Overview
6.4.3 Halocarbon Products Inhalational Anesthesia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Halocarbon Products Inhalational Anesthesia Drugs Product Portfolio
6.4.5 Halocarbon Products Recent Developments/Updates
6.5 Jiangsu Hengrui Medicine
6.5.1 Jiangsu Hengrui Medicine Company Information
6.5.2 Jiangsu Hengrui Medicine Description and Business Overview
6.5.3 Jiangsu Hengrui Medicine Inhalational Anesthesia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Jiangsu Hengrui Medicine Inhalational Anesthesia Drugs Product Portfolio
6.5.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Company Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Inhalational Anesthesia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Fresenius Kabi Inhalational Anesthesia Drugs Product Portfolio
6.6.5 Fresenius Kabi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhalational Anesthesia Drugs Industry Chain Analysis
7.2 Inhalational Anesthesia Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhalational Anesthesia Drugs Production Mode & Process Analysis
7.4 Inhalational Anesthesia Drugs Sales and Marketing
7.4.1 Inhalational Anesthesia Drugs Sales Channels
7.4.2 Inhalational Anesthesia Drugs Distributors
7.5 Inhalational Anesthesia Drugs Customer Analysis
8 Inhalational Anesthesia Drugs Market Dynamics
8.1 Inhalational Anesthesia Drugs Industry Trends
8.2 Inhalational Anesthesia Drugs Market Drivers
8.3 Inhalational Anesthesia Drugs Market Challenges
8.4 Inhalational Anesthesia Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Inhalational Anesthesia Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Inhalational Anesthesia Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Inhalational Anesthesia Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Inhalational Anesthesia Drugs Sales (K MT) of Key Manufacturers (2020-2025)
 Table 5. Global Inhalational Anesthesia Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Inhalational Anesthesia Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Inhalational Anesthesia Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Inhalational Anesthesia Drugs Average Price (USD/MT) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Inhalational Anesthesia Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Inhalational Anesthesia Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Inhalational Anesthesia Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Inhalational Anesthesia Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Inhalational Anesthesia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalational Anesthesia Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Inhalational Anesthesia Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Inhalational Anesthesia Drugs Sales by Region (2020-2025) & (K MT)
 Table 18. Global Inhalational Anesthesia Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Inhalational Anesthesia Drugs Sales by Region (2026-2031) & (K MT)
 Table 20. Global Inhalational Anesthesia Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Inhalational Anesthesia Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Inhalational Anesthesia Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Inhalational Anesthesia Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Inhalational Anesthesia Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Inhalational Anesthesia Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Inhalational Anesthesia Drugs Sales by Country (2020-2025) & (K MT)
 Table 27. North America Inhalational Anesthesia Drugs Sales by Country (2026-2031) & (K MT)
 Table 28. North America Inhalational Anesthesia Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Inhalational Anesthesia Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Inhalational Anesthesia Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Inhalational Anesthesia Drugs Sales by Country (2020-2025) & (K MT)
 Table 32. Europe Inhalational Anesthesia Drugs Sales by Country (2026-2031) & (K MT)
 Table 33. Europe Inhalational Anesthesia Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Inhalational Anesthesia Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Inhalational Anesthesia Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Inhalational Anesthesia Drugs Sales by Region (2020-2025) & (K MT)
 Table 37. Asia Pacific Inhalational Anesthesia Drugs Sales by Region (2026-2031) & (K MT)
 Table 38. Asia Pacific Inhalational Anesthesia Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Inhalational Anesthesia Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Inhalational Anesthesia Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Inhalational Anesthesia Drugs Sales by Country (2020-2025) & (K MT)
 Table 42. Latin America Inhalational Anesthesia Drugs Sales by Country (2026-2031) & (K MT)
 Table 43. Latin America Inhalational Anesthesia Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Inhalational Anesthesia Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Inhalational Anesthesia Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Inhalational Anesthesia Drugs Sales by Country (2020-2025) & (K MT)
 Table 47. Middle East and Africa Inhalational Anesthesia Drugs Sales by Country (2026-2031) & (K MT)
 Table 48. Middle East and Africa Inhalational Anesthesia Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Inhalational Anesthesia Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Inhalational Anesthesia Drugs Sales (K MT) by Type (2020-2025)
 Table 51. Global Inhalational Anesthesia Drugs Sales (K MT) by Type (2026-2031)
 Table 52. Global Inhalational Anesthesia Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Inhalational Anesthesia Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Inhalational Anesthesia Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Inhalational Anesthesia Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Inhalational Anesthesia Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Inhalational Anesthesia Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Inhalational Anesthesia Drugs Price (USD/MT) by Type (2020-2025)
 Table 59. Global Inhalational Anesthesia Drugs Price (USD/MT) by Type (2026-2031)
 Table 60. Global Inhalational Anesthesia Drugs Sales (K MT) by Application (2020-2025)
 Table 61. Global Inhalational Anesthesia Drugs Sales (K MT) by Application (2026-2031)
 Table 62. Global Inhalational Anesthesia Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Inhalational Anesthesia Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Inhalational Anesthesia Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Inhalational Anesthesia Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Inhalational Anesthesia Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Inhalational Anesthesia Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Inhalational Anesthesia Drugs Price (USD/MT) by Application (2020-2025)
 Table 69. Global Inhalational Anesthesia Drugs Price (USD/MT) by Application (2026-2031)
 Table 70. Baxter Company Information
 Table 71. Baxter Description and Business Overview
 Table 72. Baxter Inhalational Anesthesia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. Baxter Inhalational Anesthesia Drugs Product
 Table 74. Baxter Recent Developments/Updates
 Table 75. AbbVie Company Information
 Table 76. AbbVie Description and Business Overview
 Table 77. AbbVie Inhalational Anesthesia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. AbbVie Inhalational Anesthesia Drugs Product
 Table 79. AbbVie Recent Developments/Updates
 Table 80. Piramal Enterprises Company Information
 Table 81. Piramal Enterprises Description and Business Overview
 Table 82. Piramal Enterprises Inhalational Anesthesia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. Piramal Enterprises Inhalational Anesthesia Drugs Product
 Table 84. Piramal Enterprises Recent Developments/Updates
 Table 85. Halocarbon Products Company Information
 Table 86. Halocarbon Products Description and Business Overview
 Table 87. Halocarbon Products Inhalational Anesthesia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Halocarbon Products Inhalational Anesthesia Drugs Product
 Table 89. Halocarbon Products Recent Developments/Updates
 Table 90. Jiangsu Hengrui Medicine Company Information
 Table 91. Jiangsu Hengrui Medicine Description and Business Overview
 Table 92. Jiangsu Hengrui Medicine Inhalational Anesthesia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. Jiangsu Hengrui Medicine Inhalational Anesthesia Drugs Product
 Table 94. Jiangsu Hengrui Medicine Recent Developments/Updates
 Table 95. Fresenius Kabi Company Information
 Table 96. Fresenius Kabi Description and Business Overview
 Table 97. Fresenius Kabi Inhalational Anesthesia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. Fresenius Kabi Inhalational Anesthesia Drugs Product
 Table 99. Fresenius Kabi Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Inhalational Anesthesia Drugs Distributors List
 Table 103. Inhalational Anesthesia Drugs Customers List
 Table 104. Inhalational Anesthesia Drugs Market Trends
 Table 105. Inhalational Anesthesia Drugs Market Drivers
 Table 106. Inhalational Anesthesia Drugs Market Challenges
 Table 107. Inhalational Anesthesia Drugs Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Inhalational Anesthesia Drugs
 Figure 2. Global Inhalational Anesthesia Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Inhalational Anesthesia Drugs Market Share by Type: 2024 & 2031
 Figure 4. Sevoflurane Product Picture
 Figure 5. Desflurane Product Picture
 Figure 6. Isoflurane Product Picture
 Figure 7. Enflurane Product Picture
 Figure 8. Global Inhalational Anesthesia Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Inhalational Anesthesia Drugs Market Share by Application: 2024 & 2031
 Figure 10. Hospitals
 Figure 11. Clinics
 Figure 12. Ambulatory Surgical Centers
 Figure 13. Global Inhalational Anesthesia Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Inhalational Anesthesia Drugs Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Inhalational Anesthesia Drugs Sales (2020-2031) & (K MT)
 Figure 16. Global Inhalational Anesthesia Drugs Average Price (USD/MT) & (2020-2031)
 Figure 17. Inhalational Anesthesia Drugs Report Years Considered
 Figure 18. Inhalational Anesthesia Drugs Sales Share by Manufacturers in 2024
 Figure 19. Global Inhalational Anesthesia Drugs Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Inhalational Anesthesia Drugs Players: Market Share by Revenue in Inhalational Anesthesia Drugs in 2024
 Figure 21. Inhalational Anesthesia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Inhalational Anesthesia Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Inhalational Anesthesia Drugs Sales Market Share by Country (2020-2031)
 Figure 24. North America Inhalational Anesthesia Drugs Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Inhalational Anesthesia Drugs Sales Market Share by Country (2020-2031)
 Figure 28. Europe Inhalational Anesthesia Drugs Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Inhalational Anesthesia Drugs Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Inhalational Anesthesia Drugs Revenue Market Share by Region (2020-2031)
 Figure 36. China Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Inhalational Anesthesia Drugs Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Inhalational Anesthesia Drugs Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Inhalational Anesthesia Drugs Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Inhalational Anesthesia Drugs Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Inhalational Anesthesia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Inhalational Anesthesia Drugs by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Inhalational Anesthesia Drugs by Type (2020-2031)
 Figure 58. Global Inhalational Anesthesia Drugs Price (USD/MT) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Inhalational Anesthesia Drugs by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Inhalational Anesthesia Drugs by Application (2020-2031)
 Figure 61. Global Inhalational Anesthesia Drugs Price (USD/MT) by Application (2020-2031)
 Figure 62. Inhalational Anesthesia Drugs Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String